APA

Millot F., Guilhot J., Baruchel A., Petit A., Bertrand Y., Mazingue F., Lutz P., Vérité C., Berthou C., Galambrun C., Sirvent N., Yakouben K., Schmitt C., Gandemer V., Reguerre Y., Couillault G., Mechinaud F. & Cayuela J. (20150303). Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study. : Blood.

Chicago

Millot Frédéric, Guilhot Joelle, Baruchel André, Petit Arnaud, Bertrand Yves, Mazingue Françoise, Lutz Patrick, Vérité Cecile, Berthou Christian, Galambrun Claire, Sirvent Nicolas, Yakouben Karima, Schmitt Claudine, Gandemer Virginie, Reguerre Yves, Couillault Gérard, Mechinaud Françoise and Cayuela Jean-Michel. 20150303. Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study. : Blood.

Harvard

Millot F., Guilhot J., Baruchel A., Petit A., Bertrand Y., Mazingue F., Lutz P., Vérité C., Berthou C., Galambrun C., Sirvent N., Yakouben K., Schmitt C., Gandemer V., Reguerre Y., Couillault G., Mechinaud F. and Cayuela J. (20150303). Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study. : Blood.

MLA

Millot Frédéric, Guilhot Joelle, Baruchel André, Petit Arnaud, Bertrand Yves, Mazingue Françoise, Lutz Patrick, Vérité Cecile, Berthou Christian, Galambrun Claire, Sirvent Nicolas, Yakouben Karima, Schmitt Claudine, Gandemer Virginie, Reguerre Yves, Couillault Gérard, Mechinaud Françoise and Cayuela Jean-Michel. Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study. : Blood. 20150303.